Montecillo, Rosindo D.
HRN: 08-12-46 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/21/2025
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
06/21/2025
06/28/2025
IV
750mg
Q24
Hospital Acquired Pneumonia
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes